Strong JM[au] - Search Results

Year	Number of Results
1950	1
1955	1
1956	1
1957	1
1958	1
1963	1
1973	2
1974	3
1975	6
1976	2
1977	6
1979	3
1980	5
1981	4
1982	3
1983	2
1984	3
1985	2
1986	2
1987	2
1988	1
1989	1
1990	1
1992	2
1993	1
1994	1
1995	3
1996	5
1997	5
1998	3
1999	1
2001	2
2002	2
2005	1
2006	2
2008	3
2009	2
2010	1
2011	3
2012	2
2013	1
2015	1
2020	1
2021	1
2022	0

1

The Gut Microbiome and Bone Strength.

Castaneda M, Strong JM, Alabi DA, Hernandez CJ. Castaneda M, et al. Among authors: strong jm. Curr Osteoporos Rep. 2020 Dec;18(6):677-683. doi: 10.1007/s11914-020-00627-x. Epub 2020 Oct 8. Curr Osteoporos Rep. 2020. PMID: 33030683 Free PMC article. Review.

2

Components of the Gut Microbiome That Influence Bone Tissue-Level Strength.

Luna M, Guss JD, Vasquez-Bolanos LS, Castaneda M, Rojas MV, Strong JM, Alabi DA, Dornevil SD, Nixon JC, Taylor EA, Donnelly E, Fu X, Shea MK, Booth SL, Bicalho R, Hernandez CJ. Luna M, et al. Among authors: strong jm. J Bone Miner Res. 2021 Sep;36(9):1823-1834. doi: 10.1002/jbmr.4341. Epub 2021 Jun 4. J Bone Miner Res. 2021. PMID: 33999456

3

A regulatory viewpoint on transporter-based drug interactions.

Zhang L, Zhang YD, Strong JM, Reynolds KS, Huang SM. Zhang L, et al. Among authors: strong jm. Xenobiotica. 2008 Jul;38(7-8):709-24. doi: 10.1080/00498250802017715. Xenobiotica. 2008. PMID: 18668428 Review.

4

Scientific perspectives on drug transporters and their role in drug interactions.

Zhang L, Strong JM, Qiu W, Lesko LJ, Huang SM. Zhang L, et al. Among authors: strong jm. Mol Pharm. 2006 Jan-Feb;3(1):62-9. doi: 10.1021/mp050095h. Mol Pharm. 2006. PMID: 16686370 Review.

5

New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process.

Huang SM, Strong JM, Zhang L, Reynolds KS, Nallani S, Temple R, Abraham S, Habet SA, Baweja RK, Burckart GJ, Chung S, Colangelo P, Frucht D, Green MD, Hepp P, Karnaukhova E, Ko HS, Lee JI, Marroum PJ, Norden JM, Qiu W, Rahman A, Sobel S, Stifano T, Thummel K, Wei XX, Yasuda S, Zheng JH, Zhao H, Lesko LJ. Huang SM, et al. Among authors: strong jm. J Clin Pharmacol. 2008 Jun;48(6):662-70. doi: 10.1177/0091270007312153. Epub 2008 Mar 31. J Clin Pharmacol. 2008. PMID: 18378963 Review.

6

French maritime pine bark extract (Pycnogenol®) and the use of health supplements in the age of personalized medicine.

Strong JM. Strong JM. Panminerva Med. 2011 Sep;53(3 Suppl 1):1-2. Panminerva Med. 2011. PMID: 22108470 No abstract available.

7

Quantitation of 4-hydroxycyclophosphamide/aldophosphamide in whole blood.

Anderson LW, Ludeman SM, Colvin OM, Grochow LB, Strong JM. Anderson LW, et al. Among authors: strong jm. J Chromatogr B Biomed Appl. 1995 May 19;667(2):247-57. doi: 10.1016/0378-4347(95)00036-i. J Chromatogr B Biomed Appl. 1995. PMID: 7663697 Free article.

8

Pharmacological activity, metabolism, and pharmacokinetics of glycinexylidide.

Strong JM, Mayfield DE, Atkinson AJ Jr, Burris BC, Raymon F, Webster LT Jr. Strong JM, et al. Clin Pharmacol Ther. 1975 Feb;17(2):184-94. doi: 10.1002/cpt1975172184. Clin Pharmacol Ther. 1975. PMID: 1122677

9

THE TREATMENT OF DUPUYTREN'S CONTRACTURE BY PARTIAL FASCIECTOMY.

FREEHAFER AA, STRONG JM. FREEHAFER AA, et al. Among authors: strong jm. J Bone Joint Surg Am. 1963 Sep;45:1207-16. J Bone Joint Surg Am. 1963. PMID: 14077984 No abstract available.

10

Efficacy of oral administration of Lentinula eododes mycelia extract for breast cancer patients undergoing postoperative hormone therapy.

Suzuki N, Takimoto Y, Suzuki R, Arai T, Uebaba K, Nakai M, Strong JM, Tokuda H. Suzuki N, et al. Among authors: strong jm. Asian Pac J Cancer Prev. 2013;14(6):3469-72. doi: 10.7314/apjcp.2013.14.6.3469. Asian Pac J Cancer Prev. 2013. PMID: 23886130 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results